FDA.reportPublic FDA data

lidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical Gel

RxCUI
1189623
RxNorm name
lidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical Gel
Term type
SCD
Status
Active
Updated
2026-06-17 07:05:48

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112011
Active start
112011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
lidocaine hydrochloride0.005 MG / 1 MGlidocainelidocaine hydrochloride
menthol0.001 MG / 1 MGmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Gel346286

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
lidocaine6387
menthol6750

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRlidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical GelNAMES
RxNorm Namelidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical GelNAMES
RxNorm Synonymlidocaine hydrochloride 0.5 % / menthol 0.1 % Topical GelNAMES
TTYSCDATTRIBUTES
RxCUI1189623CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
00363400319rxnav_historical
56062070216rxnav_historical
67732040819rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e0a3749b-0bce-4ebf-bb43-000375ff5947lidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical GelSCD2Drug Facts20121115
e0a3749b-0bce-4ebf-bb43-000375ff5947lidocaine hydrochloride 0.5 % / menthol 0.1 % Topical GelSY2Drug Facts20121115
e0a3749b-0bce-4ebf-bb43-000375ff5947lidocaine HCl 0.5 % / menthol 0.1 % Topical GelPSN2Drug Facts20121115
d227f447-e129-4c34-8300-d00580e61daalidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical GelSCD1Drug Facts20121114
d227f447-e129-4c34-8300-d00580e61daalidocaine hydrochloride 0.5 % / menthol 0.1 % Topical GelSY1Drug Facts20121114
d227f447-e129-4c34-8300-d00580e61daalidocaine HCl 0.5 % / menthol 0.1 % Topical GelPSN1Drug Facts20121114

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
7cfe1d6c-9f7b-4a6d-88b6-fbf3d9c9d1e2Drug FactsWALGREEN CO.20121204
e0a3749b-0bce-4ebf-bb43-000375ff5947Drug FactsPublix Super Markets Inc20121115
d227f447-e129-4c34-8300-d00580e61daaDrug FactsDUANE READE INC.20121114

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.005 MG/MG / 0.001 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1189623
NAMESPrescribable Synonymlidocaine HCl 0.5 % / menthol 0.1 % Topical Gel
NAMESRXNAV_STRlidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical Gel
NAMESRxNorm Namelidocaine hydrochloride 0.005 MG/MG / menthol 0.001 MG/MG Topical Gel
NAMESRxNorm Synonymlidocaine hydrochloride 0.5 % / menthol 0.1 % Topical Gel